Massachusetts technology center houses emerging biotech firms

03/14/2011 | Boston Globe (tiered subscription model), The

The Riverside Technology Center in Cambridge, Mass., accommodates several biotech startups that could become the next Genzyme or Vertex Pharmaceuticals. Among these companies are Bluebird Bio, which is developing gene therapies for rare conditions, and Cerulean Pharma, which is working on a nanoparticle technology that can deliver drugs directly to tumors.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC